Fresh science and technology news from Iraq

Provided by AGP

Tech News Iraq: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.

Press releases published on May 7, 2026

Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
Kodiak AI Reports First Quarter 2026 Results; Announces $100 Million PIPE Financing
Microchip Technology Announces Financial Results for Fourth Quarter and Fiscal Year 2026
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2026 Financial Results
Nephros Announces Financial Results for Quarter Ended March 31, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GSI Technology, Inc. Announces Fourth Quarter and Fiscal Year 2026 Results
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
Sprout Social Announces First Quarter 2026 Financial Results
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
LiveRamp to Discuss Fourth Quarter FY26 Financial Results
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
Phunware Reports First Quarter 2026 Financial Results

Share us

on your social networks:

Sign up for:

Tech News Iraq

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.